UK Medtechs Rue Low Cap Of Rules-Based Innovation Adoption Plan, Note AI Airlock Progress

Pathway To Adequate Funding For Medtech Adoption ‘Still Not There’ ABHI Warns

The NHS England and NICE “rules-based pathway” plan for medtech innovation adoption includes a proposed funding cap that could stymie its aims. Elsewhere, progress is reported on the MHRA’s AI Airlock and UK post-market surveillance.

Checklist_Needs_Improvement

The joint NHS England and National Institute for Health and Care Excellence (NICE) initiative to set a “rules-based pathway” to promote improved adoption of medical technology by the national healthcare provider is “a good first step.”

That was the view of Andrew Davies, digital health lead at the Association of British HealthTech Industries (ABHI), as he opened the 17 September Westminster Health Forum on “Next Steps on Digital Health and Medical Technology

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe

Disparities — Including Financials Shortcomings — Remain In Women’s Health, Execs Say

 

FemTech leaders discussed some of the barriers that remain in unlocking the full potential of the women’s health market during SiS New York last week. They also offered solutions.

Thousands Of Cardiac Digital Twins Reveal Novel Connections With Mental Health

 

King’s College London, Imperial College London and The Alan Turing Institute constructed cardiac digital twins at scale, creating over 3,400, in a new study using UK Biobank data published in Nature Cardiovascular Research on 16 May.

LSX Europe: Women’s Health Education Is The Key For Unlocking VC Investment

 

Flo Health was the first femtech unicorn to be valued at over $1bn. But the company faced 49 investment rejections before reaching that status, Anna Klepchukova, the company’s chief medical officer, told the LSX World Congress Europe. THENA Capital’s Esther Reynal de St Michel Richardot talked through the firm’s gender-smart investment strategy.